PUBLICATIONS · 27621395
PANCREOX: A Randomized Phase III Study of Fluorouracil/Leucovorin With or Without Oxaliplatin for Second-Line Advanced Pancreatic Cancer in Patients Who Have Received Gemcitabine-Based Chemotherapy.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2016 Nov 10
- First author
- Gill S
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2017 Apr 20;35(12):1371. doi: 10.1200/JCO.2016.71.3883.
- note
- Source null
- related pmid
- 28113014
- relationship
- Comment in
- citation
- J Clin Oncol. 2017 Apr 20;35(12):1370-1371. doi: 10.1200/JCO.2016.71.0921.
- note
- Source null
- related pmid
- 28113022
- relationship
- Comment in
Authors and identifiers
- name
- Gill S
- type
- Author
- name
- Ko YJ
- type
- Author
- name
- Cripps C
- type
- Author
- name
- Beaudoin A
- type
- Author
- name
- Dhesy-Thind S
- type
- Author
- name
- Zulfiqar M
- type
- Author
- name
- Zalewski P
- type
- Author
- name
- Do T
- type
- Author
- name
- Cano P
- type
- Author
- name
- Lam WYH
- type
- Author
- name
- Dowden S
- type
- Author
- name
- Grassin H
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Gill S
- type
- Author
- name
- Ko YJ
- type
- Author
- name
- Cripps C
- type
- Author
- name
- Beaudoin A
- type
- Author
- name
- Dhesy-Thind S
- type
- Author
- name
- Zulfiqar M
- type
- Author
- name
- Zalewski P
- type
- Author
- name
- Do T
- type
- Author
- name
- Cano P
- type
- Author
- name
- Lam WYH
- type
- Author
- name
- Dowden S
- type
- Author
- name
- Grassin H
- type
- Author
- bibliography ids
- nci-bib-5f06893e079794b49922e261
- book metadata
- content sha256
- a484083cce6f2e7254150fcf5702ec0241074e4f256747cb1bbbd24644162827
- document type
- citation
- dois
- 10.1200/JCO.2016.68.5776
- electronic publication date
- display
- 2016 Sep 30
- precision
- day
- year
- 2016
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:27621395
- immutable id
- pubmed:27621395@a484083cce6f2e7254150fcf5702ec0241074e4f256747cb1bbbd24644162827
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 32
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 3914-3920
- volume
- 34
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2017 Apr 20;35(12):1371. doi: 10.1200/JCO.2016.71.3883.
- note
- Source null
- related pmid
- 28113014
- relationship
- Comment in
- citation
- J Clin Oncol. 2017 Apr 20;35(12):1370-1371. doi: 10.1200/JCO.2016.71.0921.
- note
- Source null
- related pmid
- 28113022
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 27621395
- provenance
- batch id
- d649bcb2d98dbbacd53c
- provider
- NCBI PubMed ESummary
- record sha256
- 0f293c521d977b4234fb27b7e5fd56ccc9f305180fdf6297e17659540fd26b31
- response sha256
- 26648a40f123f366675007f51cc29befd1f9a89273ca2da87c477c54d2d15d20
- retrieved at
- 2026-09-09T23:47:20.761544+00:00
- publication date
- display
- 2016 Nov 10
- precision
- day
- year
- 2016
- publication types
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- PANCREOX: A Randomized Phase III Study of Fluorouracil/Leucovorin With or Without Oxaliplatin for Second-Line Advanced Pancreatic Cancer in Patients Who Have Received Gemcitabine-Based Chemotherapy.
Preserved source evidence · Not medical advice
Triangle